BHLHE22 and endometrial cancer: In humans, Bhlhe22 has been identified as a highly methylated gene in endometrial cancer with potential epigenetic biomarkers in cervical scrapings (Liew et al., 2019), while Bhlhe23 has been linked to mammalian retinal development (Woods et al., 2018).